Diabetes Mellitus, Type 2, drug therapy

All categories
Name
Diabetes Mellitus, Type 2, drug therapy
Accession Number
DBCAT003023
Description

Not Available

Drugs
DrugDrug Description
GemigliptinA dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.
GosogliptinGosogliptin has been used in trials studying the treatment of Renal Insufficiency, Chronic.
BexagliflozinA sodium-glucose co-transporter 2 inhibitor used to improve glycemic control in patients with type 2 diabetes mellitus.
Drugs & Drug Targets
DrugTargetType
GosogliptinDipeptidyl peptidase 4target
BexagliflozinUDP-glucuronosyltransferase 1-9enzyme
BexagliflozinCytochrome P450 3A4enzyme
BexagliflozinCytochrome P450 2C8enzyme
BexagliflozinCytochrome P450 2D6enzyme
BexagliflozinUDP-glucuronosyltransferase 1-1enzyme
BexagliflozinSodium/glucose cotransporter 2target
BexagliflozinP-glycoprotein 1transporter